For life sciences organizations, data is no longer a departmental asset. It has become an enterprise capability; one that must move frictionlessly across research, clinical, medical, commercial, and operational functions to support better decisions, stronger governance, and more scalable innovation.

That shift is redefining what enterprise data strategy means. The conversation is no longer limited to what an individual function needs to achieve its own objectives. Leaders are increasingly asking how the data produced in one part of the organization can serve consumers elsewhere, how quality and context can be preserved across the data lifecycle, and how enterprise-wide use cases can be enabled without slowing the business down.

For leaders, the mandate is to build enterprise data and AI capabilities that are trusted, reusable, outcome-driven, and ready for a future in which both humans and intelligent agents consume data. That requires more than technology investment. It requires business partnership, shared accountability, disciplined governance, and a sustained commitment to helping people and processes evolve.

Read the full article for a deep dive into why trusted data, responsible AI, and enterprise-wide governance now comprise the new operating model for life sciences innovation.